In addition, CEP192 was increased not only in HCC but also in other types of cancer, including cholangiocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, and lung adenocarcinoma (Figure S1B). This evidence concerns the gene CEP192 and hepatocellular carcinoma.